The sleep monitor Sleepiz One+ from the Zurich-based company Sleepiz has been approved by the US Food and Drug Administration (FDA) for use as a medical product. The small cube is placed next to the bed to measure a patient’s macro and micro movements in a contactless manner to determine their vital signs. These can contribute to the early detection of deteriorating health in patients, for example in the case of chronic illnesses.
As the spin-off from the Swiss Federal Institute of Technology in Zurich (ETH) writes in a press release, the FDA approval opens the door to the seamless integration of the Sleepiz One+ in remote patient monitoring processes and clinical trial platforms in the USA as well. Sleepiz was awarded the European Union’s CE mark back in October 2020.
Read more here www.swisstrade.com